Companies

BioDevek is a medical device company whose mission is to transform the field of surgical
Alumni
Antibody therapeutics for the immune synapse.
Alumni
QuickFire
Challenge Winner
Cyteir is revolutionizing the concept of DNA damage and repair. Conventional therapies
Alumni
Dragonfly Therapeutics develops novel first-in-class therapeutics targeted at Natural
Glympse Bio is developing a powerful new paradigm in diagnostics designed to enable
Alumni
HiFiBiO SAS commercializes proprietary single cell technologies for applications in drug
Kymera Therapeutics is a seed-stage therapeutics company focused on targeting the
Alumni
A powerful therapeutic approach targeting the central regulator of nutrient signaling,
Alumni
Developing next-generation cell and gene therapeutics that employ precise exogenous
A pre-clinical-stage company, PanTher Therapeutics is working to revolutionize the
QurAlis Corporation is a new private biotech company focused on developing precision
Alumni
QuickFire
Challenge Winner
Riparian is discovering novel therapeutics to reduce vascular inflammation and treat
TorpedoDx is reducing global cancer mortality through the early detection of cancer,
Alumni
QuickFire
Challenge Winner
XTuit Pharmaceuticals is pursuing novel approaches to improving cancer therapy by